January 23, 2008 – Vapotherm said this week its U.S. patent rights have been validated for an apparatus used in the delivery tube technology for respiratory tract therapy.
U.S. Patent No. 7,314,046 B2 has been granted through 2022 and provides Vapotherm the right to prevent or exclude other companies from making, using, selling, or offering to sell or import the invention.
The triple lumen design is the vital component for Vapotherm products as it helps deliver humidified air to the respiratory tract of patients. Used throughout all Vapotherm products, including the 2000i and the recently introduced Precision Flow, the company says the apparatus allows Vapotherm to maintain the conditioned breathing gases to the patient and aid with respiratory tract therapy and treatment.
For more information: www.vtherm.com
February 23, 2026 
